Introduction
============

Remifentanil (R) a new short-acting opioid, has been introduced in cardiac total intravenous anesthesia to solve the problems connected with the adminstration of long-acting opioids. Aim of our study was to evaluate the efficacy of R in optimizing mechanical ventilation and ICU stay after cardiac surgery.

Methods
=======

We studied 30 consecutive pts, EF \>40% scheduled for elective coronary surgery. Pts were randomized in two different groups: Group R (16 pts) receiving remifentanil, and group F treated with moderate dose fentanyl (14 pts). Induction of anesthesia was performed in both groups with fentanyl 15 μg/kg per min, vecuronium 0.15 mg/kg and thiopentone 0.5--1 mg/kg. In group R anesthesia was then maintained with continuous infusion of propofol 1--3 mg/kg per h and remifentanil 0.5--1 μg/kg per min running throughout the surgical procedure. In group F the maintenance was obtained with propofol 1--3 mg/kg per h and fenatyl 5--7 μg/kg per h running throughout the surgical procedure too. Propofol was continued at dose 0.5--1 mg/kg per h in the ICU until 30 min previous extubation in all pts. In adjunction pts of group R received remifentanil 0.1--0.2 μg/kg per min until extubation. In both groups we evaluated the duration of mechanical ventilation and of ICU stay. All data were analysed with t-test (*P* \< 0.05).

Results
=======

Mean time of mechanical ventilation was 4 ± 1.3 h in group F vs 9 ± 15 h in group R (*P* \< 0.05). In group R mean ICU stay was shorter than group F: 18 h vs 27 h (*P* \< 0.05). Global ICU cost charge/pt was \$930 in group R vs \$1390 in group F, according to DRG coefficients.

Discussion
==========

Our experience suggests that remifentanil, combined with propofol, can improve early extubation and reduce ICU stay in uncomplicated CABG pts with good EF, so leading to a trend in cost reduction.
